E Fund Management’s AstraZeneca AZN Stock Holding History

E Fund Management’s Portfolio AZN Stock Details AZN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	$970K	Sell	6,944 -483	-7%	-$67.7K	0.05%	174
2025 Q1	$1.09M	Buy	7,427 +3,967	+115%	+$574K	0.05%	160
2024 Q4	$453K	Buy	3,460 +744	+27%	+$104K	0.02%	240
2024 Q3	$423K	Buy	2,716 +227	+9%	+$36.6K	0.02%	215
2024 Q2	$388K	Buy	2,489 +53	+2%	+$7.97K	0.02%	200
2024 Q1	$330K	Sell	2,436 -70	-3%	-$9.27K	0.02%	266
2023 Q4	$338K	Sell	2,506 -242	-9%	-$31.5K	0.02%	218
2023 Q3	$372K	Buy	2,748 +538	+24%	+$73.5K	0.03%	179
2023 Q2	$316K	Sell	2,210 -475	-18%	-$69.9K	0.03%	211
2023 Q1	$373K	Sell	2,685 -217	-7%	-$29.2K	0.03%	191
2022 Q4	$394K	Buy	2,902 +6	+0.2%	+$752	0.03%	183
2022 Q3	$318K	Buy	2,896 +137	+5%	+$17.4K	0.03%	226
2022 Q2	$365K	Buy	2,759 +45	+2%	+$5.9K	0.03%	201
2022 Q1	$360K	Buy	+2,714	New	+$325K	0.01%	164

Other funds holding AZN

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

Sanders Capital West Palm Beach, Florida $99.8B AUM 47.9% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

E Fund Management's AZN Position: Q2 2025 in Review

E Fund Management reduced its AstraZeneca (AZN) stake by 6.5% in Q2 2025, selling an estimated $67.7K and leaving 6,944 shares worth $970K. The position accounts for 0.05% of the portfolio, ranked #174.

E Fund Management first reported a position in AZN in Q1 2022 and has held it in 14 quarters since. The position peaked at $1.09M in Q1 2025. 1,222 funds tracked by Wall St. Rank hold AZN as of Q2 2025.

E Fund Management held 6,944 shares of AstraZeneca worth $970K as of Q2 2025.
E Fund Management sold 483 AstraZeneca shares in Q2 2025, an estimated $67.7K.
AstraZeneca made up 0.05% of E Fund Management's portfolio in Q2 2025, its #174 holding.
E Fund Management first reported a position in AstraZeneca in Q1 2022 and has held it in 14 quarters since.
E Fund Management's AstraZeneca position peaked at $1.09M in Q1 2025.
1,222 funds tracked by Wall St. Rank held AstraZeneca as of Q2 2025.

Based on E Fund Management's 13F filing for Q2 2025, filed 15 Aug 2025.